Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,885 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multidrug- and extensively drug-resistant tuberculosis, Germany.
Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group. Eker B, et al. Among authors: lange c. Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729. Emerg Infect Dis. 2008. PMID: 18976552 Free PMC article.
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Sotgiu G, et al. Among authors: lange c. J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3. J Antimicrob Chemother. 2009. PMID: 19651787 No abstract available.
What about existing databases?
Herzmann C, Günther G, Eker B, Lange C, Migliori GB. Herzmann C, et al. Among authors: lange c. Dtsch Arztebl Int. 2010 Jun;107(24):435-6; author reply 436. doi: 10.3238/arztebl.2010.0435c. Epub 2010 Jun 18. Dtsch Arztebl Int. 2010. PMID: 20607088 Free PMC article. No abstract available.
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.
Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C, Ljungman P, Milburn H, Morris MI, Muller E, Muñoz P, Nellore A, Rieder HL, Sester U, Theodoropoulos N, Wagner D, Sester M. Bumbacea D, et al. Among authors: lange c. Eur Respir J. 2012 Oct;40(4):990-1013. doi: 10.1183/09031936.00000712. Epub 2012 Apr 10. Eur Respir J. 2012. PMID: 22496318 Free article. Review.
Availability of anti-tuberculosis drugs in Europe.
Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB. Sotgiu G, et al. Among authors: lange c. Eur Respir J. 2012 Aug;40(2):500-3. doi: 10.1183/09031936.00009212. Eur Respir J. 2012. PMID: 22855471 Free article. No abstract available.
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.
Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Hollm-Delgado MG, Keshavjee S, DeRiemer K, Centis R, D'Ambrosio L, Lange CG, Bauer M, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Falzon D, et al. Eur Respir J. 2013 Jul;42(1):156-68. doi: 10.1183/09031936.00134712. Epub 2012 Oct 25. Eur Respir J. 2013. PMID: 23100499 Free PMC article.
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.
Diel R, Loddenkemper R, Zellweger JP, Sotgiu G, D'Ambrosio L, Centis R, van der Werf MJ, Dara M, Detjen A, Gondrie P, Reichman L, Blasi F, Migliori GB; European Forum for TB Innovation. Diel R, et al. Eur Respir J. 2013 Sep;42(3):785-801. doi: 10.1183/09031936.00205512. Epub 2013 Feb 8. Eur Respir J. 2013. PMID: 23397299 Free article.
2,885 results